Member News
Cayman Chemical Introduces LipidLaunch™, Expands Portfolio of Lipid Nanoparticle Research Tools to Support Advances in RNA Therapies
ANN ARBOR, MI, FEBRUARY 22, 2024 – Cayman Chemical, a leading supplier of research tools for lipid nanoparticles (LNPs), announced today the introduction of LipidLaunch™ research-ready LNPs and reagent kits. The LipidLaunch™ product line is the latest addition to the company’s portfolio of LNP research tools and reflects the company’s legacy of providing high-quality lipids…
Read MoreTrialAssure Uses Artificial Intelligence to Create Plain Language Summaries for 50,000 Studies Listed on ClinicalTrials.Gov
ORIGINAL SOURCE TrialAssure’s proprietary AI-technology can aid in making clinical trial results available more quickly to all trial participants and the public The equivalent of one million work hours completed in less than one day using AI in honor of Health Literacy Month Plain language summaries to be released over a five-week period by disease…
Read MoreMSU researchers link auto and dairy industries to explore sustainable climate solutions
ORIGINAL SOURCE Renewable electrical energy produced from anaerobic digesters could drive EV charging stations on dairy farms EAST LANSING, Mich. — One of the next climate change solutions might be found at your local dairy farm. A team of MSU researchers are studying ways to generate renewable energy from dairy farm waste to charge electric…
Read MoreTrialAssure Announces AI Generative Text Partnership with Top Clinical Research Organization MMS on New Medical Writing Initiative
TrialAssure, a leading software-as-a-service (SaaS) provider advancing clinical trial disclosure, data sharing, and transparency, announced today that it is collaborating with MMS, a global clinical research organization, on a new artificial intelligence (AI) initiative aimed at developing generative text specifically for medical writing in the field of drug development. The primary focus of this collaboration…
Read MoreNew Day Foundation for Families Announces New Day NEXT
ROCHESTER HILLS, MICH, July 1, 2023 — New Day Foundation for Families is proud to announce the launch of New Day NEXT, a young professionals’ group of passionate and motivated friends designed to cultivate the next generation of philanthropy, along with the group’s first event – a brunch following New Day’s 5K Run on Sat.,…
Read MoreCayman and Navinci Announce Strategic Partnership, Expanding Access to Next-Generation Tools for Spatial Proteomics
ORIGINAL SOURCE Ann Arbor, MI – 07/05/2023 – Global life sciences supplier Cayman Chemical (Cayman) announced today a strategic partnership with Navinci Diagnostics (Navinci), a Swedish biotechnology company developing innovative tools for spatial proteomics. This partnership expands access to Navinci’s portfolio of proximity ligation-based solutions for spatial proteomics to US- and Canada-based researchers through Cayman’s…
Read MoreNew Traceable Opioid Material® Kit Expands Coverage to Other Emerging Drugs of Concern in Seized Samples and Toxicological Casework
ORIGINAL SOURCE ANN ARBOR, MI, APRIL 26, 2023—Cayman Chemical and the Centers for Disease Control and Prevention (CDC) have released a new addition to the Traceable Opioid Material® Kits (TOM Kits®) product line that expands testing laboratory capabilities beyond synthetic opioids to include additional emerging drugs of abuse that are commonly found as co-drugs in fentanyl-containing samples. The new Fentanyl…
Read MoreMMS Scientific Advisory Board’s New Members Expand CRO’s Therapeutic Expertise
CANTON, Mich. (3/21/2023) – MMS Holdings, an award-winning, data-focused CRO, announced today the addition of Dr. Philip Breitfeld and Dr. Bernhardt Zeiher to its board of scientific advisors. Both industry leaders in innovative clinical trial delivery solutions, Dr. Breitfeld and Dr. Zeiher’s additions as advisors expand MMS’ therapeutic area expertise to support growth in different…
Read MoreMMS Partners with I-ACT to Advance Children’s Clinical Trials
CANTON, Mich. (February 21, 2023) – MMS Holdings, a data-focused contract research organization (CRO) – announced its partnership with the Institute for Advanced Clinical Trials (I-ACT) to accelerate the development of life-saving therapeutics, including vaccines, medicines, and medical devices for children. MMS is a sponsor of I-ACT’s Spin Challenge, a creative way to raise funds to…
Read MoreJASPER HEALTH AND NEW DAY FOUNDATION PARTNER TO PROVIDE FREE RESOURCES TO FAMILIES FACING CANCER
ROCHESTER HILLS, MICH., Dec. 13, 2022 – Jasper Health, an intelligent digital platform that provides end-to-end care guidance and navigation for people living with cancer, and New Day Foundation for Families, a non-profit organization that provides financial assistance and emotional support to families facing cancer, today announce a partnership to help families facing cancer access…
Read More